Q1 2019 TG Therapeutics Inc Earnings Call Transcript
Greetings and welcome to the TG Therapeutics First Quarter 2019 Financial Results and Business Update Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Jenna Bosco. Please go ahead.
Thank you. Good morning and welcome to our conference call regarding TG Therapeutics' First Quarter 2019 Financial Results and Business Update. I am Jenna Bosco, TG's Senior Vice President of Corporate Communications and I welcome you to our conference call today.
Following our safe harbor statement, Sean Power, TG's Chief Financial Officer, will provide a brief overview of our financial results and then turn the call over to Michael Weiss, the company's Executive Chairman and Chief Executive Officer, who will provide an update on the ongoing development of our lead compounds, ublituximab and umbralisib, as well a high level overview of our early stage programs and overall company standing.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |